메뉴 건너뛰기




Volumn 32, Issue 2, 2013, Pages 509-513

Targeting epidermal growth factor receptor with ferrocene-based kinase inhibitors

Author keywords

[No Author keywords available]

Indexed keywords

ANTICANCER ACTIVITIES; EPIDERMAL GROWTH; EPIDERMAL GROWTH FACTOR RECEPTORS; FERROCENES; IN-VITRO; KINASE INHIBITORS;

EID: 84872962778     PISSN: 02767333     EISSN: 15206041     Source Type: Journal    
DOI: 10.1021/om300974d     Document Type: Article
Times cited : (25)

References (37)
  • 21
    • 84872901063 scopus 로고    scopus 로고
    • Tested at Reaction Biology.
    • Tested at Reaction Biology: http://www.reactionbiology.com/.
  • 22
    • 84872928163 scopus 로고    scopus 로고
    • We only selected EGFR in this study. It is highly plausible that ferrocenes 6a-c may very well inhibit other kinases (cf. ref 5a)
    • We only selected EGFR in this study. It is highly plausible that ferrocenes 6a-c may very well inhibit other kinases (cf. ref 5a).
  • 23
    • 0016640079 scopus 로고
    • K562 is a chronic myelogenous leukemia (CML) cell line: ()
    • K562 is a chronic myelogenous leukemia (CML) cell line: Lozzio, C. B.; Lozzio, B. B. Blood 1975, 45 (3) 321
    • (1975) Blood , vol.45 , Issue.3 , pp. 321
    • Lozzio, C.B.1    Lozzio, B.B.2
  • 32
    • 33644926068 scopus 로고    scopus 로고
    • Rigaku Corporation, The Woodlands, TX.
    • CrystalClear; Rigaku Corporation, The Woodlands, TX, 2008.
    • (2008) CrystalClear
  • 34
    • 84872895515 scopus 로고    scopus 로고
    • Bruker AXS Inc. Madison, WI, 2003.
    • Sheldrick, G. M.; Bruker AXS Inc.: Madison, WI, 2003.
    • Sheldrick, G.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.